CAR T Cell Therapy, short for chimeric antigen receptor T cell therapy, represents a groundbreaking approach in the field of cancer treatment. This innovative immunotherapy harnesses the power of a patient's own immune system to combat cancer cells. With its remarkable success in treating certain types of leukemia and lymphoma, CAR T cell therapy has emerged as a game-changer, offering new hope to patients who have exhausted conventional treatment options. In this article, ... Read more

These cells are then genetically engineered in a laboratory, where a CAR construct is introduced into their DNA. The CAR consists of an antigen-binding domain, which recognizes specific molecules on cancer cells, a transmembrane domain, and an intracellular signaling domain. Once the CAR T Cell Therapy ... Read more

CAR T Cell Therapy: A Game Changer in Treating Cancer

Chimeric antigen receptor (CAR) T cell therapy has emerged as one of the most promising types of immunotherapy for cancer treatment. With CAR T cells, a patient's own T cells are engineered to attack cancer cells in a precise yet powerful way. These engineered T cells are able to recognize and eliminate cancer cells that would otherwise evade the immune system. In this article, we will explore the details of how CAR T cell ... Read more